December 13, 2007 
I only have one more post queued up on content from the Outcomes conference. Here is some data on specialty drugs that shows the growth, their percentage of the market, the prevalence, and the cost per patient.
Leave a comment
Share This
My LinkedIn Profile
WSJ Health Blog
- Is a Paleo Diet Healthier Than Standard Nutritional Guidelines?
- Small Business and the Affordable Care Act: How Has Your Business Been Affected?
- HealthCare.gov Explorer: Decode the Health Law’s Subsidies
- One Reporter, Four Families, Six Scientists and the Search to Cure a Rare Disease
- Your Responses: How Has the Health Law Affected You?
- What Does the Health Law Mean for You? Your Questions Answered
- How Has the Health Law Affected You?
- Rare Diseases and the Search for a Cure: A Reddit AMA
- Robots to Cure Rare Diseases: A Reddit Ask Me Anything (AMA)
- Six Tips For Better Napping
Drug Channels
- Drug Channels News Roundup, December 2025: The Net Pricing Drug Channel (#NPDC) Era, LillyDirect, My $0.02 on New MFPs, PBMs in Medicaid—and DCLF 2026
- 340B Hit $81 Billion in 2024: Why CMS and the IRA Are Poised to Cool the Program’s Runaway Growth (VIDEO)
- 340B Hit $81 Billion in 2024 (+23%): Why CMS and the IRA Are Poised to Cool the Program’s Runaway Growth
- Gross-to-Net Bubble Hits $356B in 2024—But Growth Slows to 10-Year Low (rerun)
- The Future of Buy-and-Bill Market Access: Five Drivers of Wholesalers’ Vertical Integration with Physician Practices (rerun)
- Who Will Pay for Prescription Drugs in 2033: DCI’s Takeaways from the Latest Government Forecasts (rerun)
- Follow the 340B Dollar: Senator Cassidy Exposes How CVS Health and Walgreens Profit as 340B Contract Pharmacies (rerun)
- How Large PBMs Make Money Today: A 2025 Drug Channels Update (rerun)
- Closing the Specialty Access Gap: How GoodRx Turns Intent Into Therapy Starts
- List Price Reductions Will Deflate the Gross-to-Net Bubble–and Threaten Pharmacy and 340B Profits from IRA-Negotiated Drugs
KevinMD Blog
- An error has occurred; the feed is probably down. Try again later.
Health Populi
- Navigating a Constellation of Uncertainties: Health/Care in 2026 (My Un-Forecast)
- The New Health Consumer Mindset and Wallet: From GLP-1s to Trading Up for Health & Longevity
- Men’s Fertility Feelings – The Influence of Trust and Social Media (My Progyny Post #3)
- Trust and AI in Healthcare: At a Crossroads, Edelman Finds
- A Month Until #CES2026 – The Journey to Our Personal Health Operating Systems
- The Home Economics of Family and Fertility: Men’s Financial Views on Their Fertility Journeys (My Progyny Post #2)
- Giving Thanks for Pinksocks Today and Every Day….celebrating the book!
- Feeling Under-Served and Overlooked: Men’s Views on Their Fertility Journeys (My Progyny Post #1)
- Where Health Meets Beauty, Mental Health, and Faith: Learning from the Farmaceutica di Santa Maria Novella
- As SNAP Benefits Were Threatened to be Cut in the U.S., Eli Lilly’s Obesity Drugs Rose to the World’s Best-Selling Drug
e-Patients
- Collaboration is the Best Medicine: Patient-Centered Collaboration Grounded in Caritas®
- Collaboration is the Best Medicine: It’s the Heart of Caregiving
- Collaboration is the Best Medicine: How to Partner with Your Doctor for Better Care
- Collaboration is the Best Medicine: Bridging the Gap in Patient Participation
- Dealing with Medical Uncertainty, Ambiguity, and Frustration
- Collaboration is the Best Medicine: The Time for Participatory Medicine is Now
- In Memory of Nancy Finn: e-Patient, Advocate, Author, SPM Supporter
- A cure for what killed Doc Tom! Can people afford it?
- Learning Health Systems Empower Every American to Actually Make America Healthy Again Together, Part 2
- Learning Health Systems Empower Every American to Actually Make America Healthy Again Together, Part 1
Enabling Healthy Decisions Blog by www.georgevanantwerp.com is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.
Contact Information
Contact me at gvanantwerp @ mac.com.
Enabling Healthy Decisions 
No comments yet... Be the first to leave a reply!